Results 61 to 70 of about 455 (134)

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines. [PDF]

Allergy Asthma Immunol Res, 2023
Kim MA, Choi JH, Shin YS, Park HS, Ye YM, KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis.   +5 more
europepmc   +1 more source

Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age. [PDF]

BMJ Paediatr Open, 2023
O'Sullivan MD, Bear N, Metcalfe J.
europepmc   +1 more source

Safety and Tolerability of Shortened Updosing with 7 Injections of Subcutaneous Allergen Immunotherapy [PDF]

Journal of Allergy and Clinical Immunology, 2019
Eike G. Wuestenberg, Andreas Horn, Hendrik Wolf, Santiago Martin Hurtado, Katerina Koutromanou, Nadia Ghaussy, Montserrat Fernandez-Rivas   +6 more
openaire   +1 more source

Reply to “Comment on: ‘Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines’” [PDF]

Journal of the American Academy of Dermatology, 2020
Sofianne, Gabrielli, Michelle, Le, Elena, Netchiporouk, Barbara, Miedzybrodzki, Sharon, Baum, Shoshana, Greenberger, Petra, Staubach-Renz, Moshe, Ben-Shoshan   +7 more
openaire   +2 more sources

Variations in protocol development during oral immunotherapy. [PDF]

J Food Allergy, 2022
Graham F.
europepmc   +1 more source

Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series. [PDF]

Ann Hematol
Della Pepa R, Leone A, Grimaldi F, Avilia S, Memoli M, Rossini B, Liberatore C, Pane F.   +7 more
europepmc   +1 more source

Egg desensitization is achieved effectively and safely through a low maintenance dose protocol. [PDF]

J Allergy Clin Immunol Glob
Toscano-Rivero D, Kimchi N, Zhao W, Abi-Rafeh J, Ke D, Lejtenyi D, Beaudette L, McCusker C, Mazer BD, Ben-Shoshan M.   +9 more
europepmc   +1 more source

Impact of oral immunotherapy on diversity of gut microbiota in food-allergic children. [PDF]

Pediatr Allergy Immunol
Bouabid T, Tremblay BL, Lavoie MÈ, Boucher-Lafleur AM, Gagnon-Brassard F, Bégin P, Lavoie S, Rochefort-Beaudoin C, Nuncio-Naud C, Parizeault G, Morin C, Girard C, Madore AM, Laprise C.   +13 more
europepmc   +1 more source

Real-life safety of peanut oral immunotherapy: Results from a French multicenter observational study. [PDF]

J Allergy Clin Immunol Glob
Michaud E, Amat F, Lambert C, Divaret-Chauveau A, Deschildre A, Peanut Oral Immunotherapy Working Party from the French Society of Allergology.   +5 more
europepmc   +1 more source